Randomized, double blind, placebo controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of lung function, mucus plugging and other lung imaging parameters in patients with asthma

drug protocol number
LPS15834
drug sponsor
SANOFI
drug study
DUPILUMAB
drug trial site
King Fahad Medical City (Riyadh)
drug status
Ongoing
drug phase